WebApr 7, 2024 · TES-1025 (CAS. 1883602-21-8, 2- [3- [ (5-cyano-6-oxo-4-thiophen-2-yl-1H-pyrimidin-2-yl) sulfanylmethyl]phenyl]acetic acid, PubChem CID: 137142885) is a potent and selective human α-amino-β-carboxymuconate-ε-semialdehyde decarboxylase (ACMSD) inhibitor with an IC 50 of 13 nM. WebNov 9, 2024 · PERUGIA, Italy, Nov. 9, 2024 /PRNewswire/ -- TES Pharma Srl, an Italian biotechnology company focused on the discovery and development of novel drug products for the treatment of diseases of high unmet medical need, congratulates Intercept Pharmaceuticals, Inc., on the presentation of data from their ongoing first-in-human …
Attrition in the Pharmaceutical Industry: Reasons, Implications, …
WebNov 9, 2024 · PERUGIA, Italy, Nov. 9 2 mins read ... TES Pharma Srl, an Italian biotechnology company focused on the discovery and development of novel drug products for the treatment of diseases of high unmet medical need, congratulates Intercept Pharmaceuticals, Inc., on the presentation of data from their ongoing first-in-human … WebFind company research, competitor information, contact details & financial data for TES PHARMA SRL of CORCIANO, PERUGIA. Get the latest business insights from Dun & … meeting alice
Tes Pharma S.r.l. LinkedIn
Webciari (TES Pharma, Perugia,Italy) with astimulating talk titled “Engineering novel drugs. Along journey into the changing landscape of drug discovery”. He focused on the exploration of novel interactive ways in the frame of TES Pharma, an innova-tive start-upaimed at converting in-depthbiological innova- WebNov 8, 2024 · TES Pharma is a research-based biotech company, located in Perugia (Italy), dedicated to the identification of novel therapeutic targets and the discovery and development of new molecules to ... WebTES Pharma Profile and History . TES Pharma is an emerging science-driven drug discovery company, located in Perugia (Italy), focussed on the discovery and development of novel small molecule therapeutics in metabolic disease and oncology. meeting alliance